13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 64 holding rows worth $2,844,802,567.
- Accession
- 0001420506-25-001293
- Filer
- CIK 1920938
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 64 entries on the cover page, a total value of $2,844,802,567 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,844,802,567 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131MAD1 | DEBT 1.250% 2/1 | 219,454,000 | $227,414,452 | dollars as filed | principal |
| NOVOCURE LTD | 67011XAB9 | NOTE 11/0 | 140,834,000 | $136,608,218 | dollars as filed | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,191,925 | $131,826,905 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 2,977,951 | $101,041,877 | dollars as filed | |
| REPLIGEN CORP | 759916AD1 | NOTE 1.000%12/1 | 98,000,000 | $95,844,000 | dollars as filed | principal |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 160,849 | $95,200,893 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,709,875 | $90,916,306 | dollars as filed | |
| IRHYTHM HOLDINGS INC | 450056AB2 | NOTE 1.500% 9/0 | 86,000,000 | $89,741,000 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 101,381,000 | $87,948,018 | dollars as filed | principal |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 530,530 | $84,279,996 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333XAH1 | NOTE 1.500% 6/1 | 92,740,000 | $82,538,600 | dollars as filed | principal |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 3,283,317 | $80,408,433 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 400,744 | $72,254,143 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 62,838,000 | $71,997,393 | dollars as filed | principal |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 127,733 | $63,559,941 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 309,339 | $63,414,495 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 624,435 | $61,456,893 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 840,945 | $59,639,819 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 556,391 | $58,243,010 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,540,362 | $57,547,924 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 854,884 | $57,516,596 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 1,327,327 | $56,544,130 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,458,808 | $54,093,776 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 302,410 | $48,167,865 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 48,594,000 | $43,807,491 | dollars as filed | principal |
| IMMUNOCORE HLDGS PLC | 45258DAB1 | NOTE 2.500% 2/0 | 51,828,000 | $43,767,971 | dollars as filed | principal |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 1,962,909 | $43,596,209 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 88,000 | $43,583,760 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 4,259,429 | $43,190,610 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,578,404 | $41,602,549 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 439,968 | $38,941,568 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,621,344 | $37,879,258 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,652,334 | $36,136,545 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 4,803,794 | $35,692,189 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,435,955 | $34,678,313 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 110,128 | $29,449,328 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 2,162,803 | $28,181,323 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 3,536,853 | $28,047,244 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 1,107,770 | $27,284,375 | dollars as filed | |
| HARROW INC | 415858109 | COM | 956,839 | $25,451,917 | dollars as filed | |
| DEXCOM INC | 252131AM9 | NOTE 0.375% 5/1 | 25,450,000 | $22,803,200 | dollars as filed | principal |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 8,353,287 | $18,460,764 | dollars as filed | |
| DEXCOM INC | 252131AK3 | NOTE 0.250%11/1 | 18,500,000 | $18,042,125 | dollars as filed | principal |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,655,690 | $17,616,542 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 106,713 | $16,632,288 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 1,572,426 | $16,133,091 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 48,690 | $16,127,589 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 234,500 | $14,965,790 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,461,826 | $14,252,804 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 81,656 | $10,389,909 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 6,622,584 | $9,735,198 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 884,306 | $8,940,334 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 980,773 | $7,424,452 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 365,247 | $7,312,245 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 375,355 | $6,808,940 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 5,818,000 | $5,793,374 | dollars as filed | principal |
| PULMONX CORP | 745848101 | COM | 752,541 | $5,064,601 | dollars as filed | |
| METSERA INC | 59267L107 | COM | 175,000 | $4,763,500 | dollars as filed | |
| AARDVARK THERAPEUTICS INC | 002942100 | COM | 500,000 | $3,755,000 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,440,499 | $3,615,652 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,472,806 | $3,189,920 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 140,000 | $1,713,600 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 825,732 | $1,312,914 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 72,083 | $453,402 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-001293 | this filing | 2025-05-15 | acceptance time not in the bulk data set |